Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 15, 2005

View Archived Issues

NeuroMolecular receives award to support memantine development efforts

OvaRex MAb evaluated in new advanced ovarian cancer study

Subutex approved in Canada for opiate addiction treatment

FDA clears randomized portion of TNFerade pancreatic cancer study to proceed

Tev-Tropin launched in U.S.

Chemotherapeutic approach to control poxvirus infection with ErbB-1 inhibitor

FK-778, an immunosuppressant, prevents HCMV signaling and replication via inhibition of DHODH

Novel cannabinoid CB1 receptor agonists claimed by AstraZeneca

Five series of Src tyrosine kinase inhibitors reported by AstraZeneca

Testosterone MDTS improves sexual desire in women with HSDD

Update on the efficacy of rhThrombin in the management of surgery-associated bleeding

Phase III data on the effects of diquafosol ophthalmic solution in patients with dry eye

Efficacy and safety of combretastatin A-4 phosphate in the treatment of retinoblastoma

Controlled-release paroxetine reported safe and effective in panic disorder

Cerebral blood flow unaltered by BIBN-4096BS in healthy subjects

New phase II prostate cancer study for KOS-862

CEP-701 evaluated in patients with refractory malignancies

Solifenacin enhances quality of life in overactive bladder patients

Amantadine reduces weight gain from olanzapine treatment

First inhibitor of p90 ribosomal S6 kinase identified

FibroGen claims new hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors

New humanized anti-beta amyloid peptide monoclonal antibodies jointly reported by Neuralab and Wyeth

Novel NMDA/NR2B antagonists discovered at Merck

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...